Testing drugs in pediatric populations: The FDA mandate

Accountability in Research

Volumn 7, Issue 1, 1999, Pages 37-58

  Tauer, Carol A ^a  

^a ST CATHERINE UNIVERSITY   (United States)

Author keywords

Drug testing; FDA policy; Institutional Review Boards; Pediatric labeling; Research ethics; Research involving children

Indexed keywords

DRUG; PLACEBO;

ADOLESCENT; AMERICAN ACADEMY OF PEDIATRICS; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CHILD; ETHICS; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; GOVERNMENT REGULATION; HEALTH CARE ORGANIZATION; HUMAN; HUMAN EXPERIMENT; JUVENILE; LEGAL APPROACH; PEDIATRICS; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; RANDOMIZATION; RESEARCH; RISK; RISK ASSESSMENT; SOCIAL CONTROL; UNITED STATES;

AMERICAN ACADEMY OF PEDIATRICS; BIOMEDICAL AND BEHAVIORAL RESEARCH; LEGAL APPROACH;

ADOLESCENT; CHILD; ETHICAL REVIEW; ETHICS; ETHICS COMMITTEES; ETHICS COMMITTEES, RESEARCH; FEDERAL GOVERNMENT; GOVERNMENT; GOVERNMENT REGULATION; GUIDELINES; HUMAN EXPERIMENTATION; HUMANS; MINORS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PLACEBOS; RANDOM ALLOCATION; RESEARCH; RISK; RISK ASSESSMENT; SOCIAL CONTROL, FORMAL; SOCIETIES; THERAPEUTIC HUMAN EXPERIMENTATION; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0033288265     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989629908573941     Document Type: Review

References (34)

1. American Academy of Pediatrics (AAP) Committee on Drugs (1995). Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 95: 286-294.
2. American Academy of Pediatrics (AAP) Committee on Drugs (1996). Unapproved uses of approved drugs: The physician, the package insert, and the Food and Drug Administration. Pediatrics 98: 143-145.
3. Appelbaum, P.S., Roth, L.H., Lidz, C.W., Benson, P. and Winslade, W. (1987). False hopes and best data: Consent to research and the therapeutic misconception. Hastings Center Report 17, 2: 20-24.
4. Code of Federal Regulations, 21 CFR 56 (1999). Food and Drug Administration: Institutional Review Boards, (http://frwebgatel.access.gpo.gov).
5. Code of Federal Regulations, 45 CFR 46: 101-124 (1991). Federal policy for the protection of human subjects. (The Common Rule.) Federal Register 56: 28003-28016.
6. Code of Federal Regulations, 45 CFR 46: 401-109 (1983). Additional protections for children involved as subjects in research. Federal Register 48: 9816-9820.
7. Cooke, R.E. (1994). Vulnerable children. In M.A. Grodin and L.H. Glantz (eds.). Children as Research Subjects: Science, Ethics, and Law, pp. 193-214. New York: Oxford University Press.
8. Cote C.J., Kauffman, R.E., Troendle, G.J. and Lambert, G.H. (1996). Is the "therapeutic orphan" about to be adopted? Pediatrics 98: 118-123.
9. Food and Drug Administration (FDA) (1997). Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; Proposed rule. Federal Register 62, 158: 43900-43916.
10. Food and Drug Administration (FDA) (1998). Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; Final rule. Federal Register 63, 231: 66631-66672.
11. Freedman, B. (1987). Equipoise and the ethics of clinical research. New England Journal of Medicine 317, 3: 141-145.
12. Freedman, B., Fuks, A. and Weijer, C. (1993). In loco parentis: Minimal risk as an ethical threshold for research upon children. Hastings Center Report 23, 2: 13-19.
13. Gidding, S.G., Camp, D., Flanagan, M.H., Kowalski, J.A., Lingl, L.L., Silverman, B.L. and Langman, C.B. (1993). A policy regarding research in healthy children. Journal of Pediatrics 123: 852-855.
14. Glantz, L.H. (1994). The law of human experimentation with children. In M.A. Grodin and L.H. Glantz (eds.). Children as Research Subjects: Science, Ethics, and Law, pp. 103-130. New York: Oxford University Press.
15. Glantz, L.H. (1998). Research with children. American Journal of Law and Medicine 24, 2 & 3: 213-244.
16. Janofsky, B.A. and Starfield, B. (1981). Assessment of risk in research on children. Journal of Pediatrics 98: 842-846.
17. Katz, J. (1993). "Ethics and clinical research" revisited. Hastings Center Report 23, 5: 31-39.
18. Kauffman, R.E. (1994). Scientific issues in biomedical research with children. In M.A. Grodin and L.H. Glantz (eds.). Children as Research Subjects: Science, Ethics, and Law, pp. 29-45. New York: Oxford University Press.
19. Kodish, E.D. et al. (1998). Informed consent in the Children's Cancer Group. Cancer 82, 12: 2467-2481.
20. Kopelman, L.M. (1989). When is the risk minimal enough for children to be used as research subjects? In L.M. Kopelman and J.C. Moskop (eds.). Children and Health Care: Moral and Social Issues, pp. 89-99. Dordrecht: Kluwer Academic Publishers.
21. Lascari, A.D. (1981). Risks of research in children. Journal of Pediatrics 98: 759-760.
22. Levine, R.J. (1989). Children as research subjects. In L.M. Kopelman and J.C. Moskop (eds.). Children and Health Care: Moral and Social Issues, pp. 73-87. Dordrecht: Kluwer Academic Publishers.
23. McCartney, J.J. (1978). Research on children: National Commission says "Yes, if. " Hastings Center Report 8, 5: 26-31.
24. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1977). Report and Recommendations: Research Involving Children. Washington, DC: Department of Health, Education, and Welfare (DHEW Publication No. (OS) 77-0004).
25. Nelson, R.M. (1998). Children as research subjects. In J.P. Kahn, A.C. Mastroianni and J. Sugarman (eds.). Beyond Consent: Seeking Justice in Research, pp. 47-66. New York: Oxford University Press.
26. National Institutes of Health (NIH) (1998). NIH policy and guidelines on the inclusion of children as participants in research involving human subjects, March 6.
27. Pear, R. (1997). President to order drug makers to conduct pediatric studies. New York Times, August 13: A17.
28. Pear, R. (1998). FDA will require companies to test drugs on children. New York Times, November 28: A1 and A10.
29. Prentice, E.D., Antonson, D.L., Jameton, A. et al. (1989). Can children be enrolled in a placebo-controlled randomized clinical trial of synthetic growth hormone? IRB 11, 1: 6-10.
30. Puglisi, J.T. (Director, Human Subject Protections, Office of Protection from Research Risks) (1999). Personal communication, January 4.
31. Shirkey, H. (1968). Editorial comment: Therapeutic orphans. Journal of Pediatrics 72: 119-120.
32. Tauer, C.A. (1994). The NIH trials of growth hormone for short stature. IRB 16, 3: 1-9.
33. Weitman, S., Ochoa, S., Sullivan, A., Shuster, J., Winick, N., Pratt, C., Vietti, T. and Harris, M. (1997). Pediatric phase II cancer chemotherapy trials: A pediatric oncology group study. Journal of Pediatric Hematology/Oncology 19, 3: 187-191.
34. Zanga, J.R. (1997). Response of the American Academy of Pediatrics. Dockets Management Branch, Food and Drug Administration, November 13.